PATENT CLAIM ANALYSIS

Application Number: 15886290
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["436", "501000"]

Abstract:
The present invention provides methods, devices, compositions (e.g., capture complexes), and kits useful for enhancing the detection of antibodies in a test sample. The methods, devices, and compositions utilize detectable Fc-binding molecules such as Protein A, Protein G, and/or an Fc-specific antibody to amplify the signal of a detected antibody in immunoassays, such as lateral flow assays.

Claim (Index 11):
The capture complex of  claim 1 , wherein the wherein the capture entity is an antigen or antigenic peptide from an organism selected from the group consisting of heartworm,  Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia ewingii, Borrelia burgdorferi, Borrelia afzelii, Borrelia garinii, Anaplasma phagocytophilum, Anaplasma platys , feline leukemia virus, parvovirus, influenza A strain, influenza B strain, avian influenza virus, respiratory syncytial virus,  Legionella , adenovirus, rotavirus, feline immunodeficiency virus, human immunodeficiency virus, and Group A  Streptococcus.

Metadata:
- Claim Count in Document: 6.0
- Percentile: 88.0
- Lexical Diversity: 1.45833
- Patent Class: 436.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13682306', '14450154', '15628864', '14885443', '14511916']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6736242798618277
- 35 USC 102 Novelty (BERT): 0.5722558333395581
- Combined Prediction Score: 0.6634874352096007
- Mean Citation Score: 273.81023
- Max Citation Score: 475.41022
- Similarity Product: 411.3413779169416

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test